The analysis of the correlation between the expression levels of immune-related genes and the prognosis of RCC allowed us to select genes derived from IFN-gamma signature, extended immune gene signature, cytotoxic T lymphocyte (CTL) signature and HLA-A and HLA-B in HLA I molecules. This evidence concerns the gene HLA-B and renal cell carcinoma.